KZIA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kazia Therapeutics Ltd ADR

NASDAQ | KZIA

6.93

USD

$0.00

(

0.00%

)

At Close (As of Oct 27, 2025)

$11.66M

Market Cap

-

P/E Ratio

-28.99

EPS

$39.04

52 Week High

$2.86

52 Week Low

HEALTHCARE

Sector

KZIA Chart

Recent Chart
Price Action

KZIA Technicals

Tags:

KZIA Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $2.3M
Total Revenue $2.3M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$28M
Selling General And Administrative $14M
Research And Development $17M
Operating Expenses $2.3M
Investment Income Net -
Net Interest Income $12K
Interest Income $12K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$27M
Income Tax Expense -$271K
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$29M
Ebitda -$27M
Net Income -$27M

Revenue & Profitability

Earnings Performance

KZIA Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (AUD)
Total Assets $22M
Total Current Assets $6.1M
Cash And Cash Equivalents At Carrying Value $1.7M
Cash And Short Term Investments $1.7M
Inventory -
Current Net Receivables $133K
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $15M
Intangible Assets Excluding Goodwill $15M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $4.4M
Other Non Current Assets -
Total Liabilities $32M
Total Current Liabilities $26M
Current Accounts Payable $4.5M
Deferred Revenue -
Current Debt -
Short Term Debt $634K
Total Non Current Liabilities $5.8M
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt $634K
Long Term Debt Noncurrent -
Short Long Term Debt Total $634K
Other Current Liabilities $21M
Other Non Current Liabilities $3.8M
Total Shareholder Equity -$10M
Treasury Stock -
Retained Earnings -$115M
Common Stock $102M
Common Stock Shares Outstanding $480K

yearly Cash Flow (As of Jun 30, 2024)

Field Value (AUD)
Operating Cashflow -$9.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.9M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $6M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $2.3M
Total Revenue $2.3M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$28M
Selling General And Administrative $14M
Research And Development $17M
Operating Expenses $2.3M
Investment Income Net -
Net Interest Income $12K
Interest Income $12K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$27M
Income Tax Expense -$271K
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$29M
Ebitda -$27M
Net Income -$27M

KZIA News

KZIA Profile

Kazia Therapeutics Ltd ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kazia Therapeutics Ltd ADR is an innovative Australian biotechnology firm based in Sydney, primarily engaged in the development of advanced cancer therapies. The company is advancing its proprietary drug candidates through clinical trials, with a particular focus on addressing significant unmet needs in oncology, including treatments for brain cancer and other solid tumors. Its lead asset, GDC-0084, targets key pathways in cancer biology, aspiring to improve patient outcomes. With a strong commitment to scientific innovation and collaborative research, Kazia is well-positioned to make meaningful contributions to the field of cancer treatment.

CODX
+264.98%
$1.28
ASST
+40.90%
$1.54
VHAI
-50.00%
$0.00
BYND
-7.77%
$2.01
BKYI
+54.18%
$1.18
CENN
-0.74%
$0.21
YDKG
+7.04%
$0.06
BURU
-4.59%
$0.38
NVDA
+2.25%
$186.26
INTC
+2.74%
$39.32
F
-4.44%
$13.22
DNN
+2.93%
$2.81
DVLT
+3.94%
$3.55
KITT
+23.04%
$2.16
HBAN
-3.42%
$15.52
T
+2.11%
$25.14
BITF
-1.97%
$4.51
JZXN
-5.44%
$0.34
TGL
+38.67%
$1.00
QCOM
+12.27%
$189.68
TSLA
+5.78%
$458.81
AXDX
-61.36%
$0.03
PLUG
-0.52%
$2.93
GPUS
+4.19%
$0.40
ABEV
+1.14%
$2.21
RGTI
+5.76%
$41.08
TLRY
-1.34%
$1.47
NUAI
+48.35%
$5.86
NEHC
+48.35%
$5.86
QBTS
+8.97%
$35.58
NAKA
+17.88%
$0.99
AMD
+1.19%
$255.93
SOFI
+3.33%
$29.97
CAN
-7.67%
$1.74
WTO
-14.44%
$0.05
RIG
-2.05%
$3.82
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BTG
-4.22%
$4.99
AAL
-3.15%
$13.34
ONDS
+6.50%
$7.94
PLTR
+3.34%
$190.80
IONZ
-10.49%
$3.41
SRM
+53.27%
$10.30
KDP
+7.16%
$29.10
NOK
+1.26%
$6.38
ADAP
-9.89%
$0.05
NIO
+2.82%
$7.09
LAES
-1.94%
$6.87
UUUU
-10.93%
$19.03
GRAB
+4.34%
$6.10
RF
-1.79%
$24.12
KDLY
+5.66%
$0.84
RIVN
+4.81%
$13.60
ACHR
+1.90%
$11.50
CIFR
-0.98%
$20.45
NVTS
-2.67%
$13.69
RR
+0.90%
$6.13
BBD
+1.34%
$3.39
WLGS
-5.57%
$0.04
JOBY
+1.16%
$16.31
RXRX
+2.77%
$6.20
IREN
+1.98%
$64.15
ETHD
-14.74%
$3.26
OGN
-22.05%
$7.14
QUBT
+3.83%
$16.12
ETWO
0.00%
$3.30
AIRE
+3.43%
$0.79
VIVK
-0.72%
$0.28
BTBT
+2.42%
$4.00
CJET
-7.05%
$0.10
MARA
+2.30%
$19.98
QS
+1.03%
$16.99
WGRX
-25.56%
$0.85
AFMD
-34.94%
$0.18
BMNR
+6.72%
$53.80
JBLU
+2.18%
$4.67
LUMN
+12.68%
$9.11
SNAP
-0.31%
$7.92
EOSE
+11.83%
$16.05
CRWV
+7.46%
$132.55
AAPL
+1.18%
$265.94
OPI
-16.97%
$0.20
AMZN
+1.55%
$227.69
MP
-6.88%
$65.93
KLG
-9.05%
$13.35
IONQ
+5.90%
$63.86
PFE
-0.14%
$24.72
GRYP
-10.38%
$1.38
VALE
+0.41%
$11.45
RECT
-7.18%
$3.23
SOUN
+2.25%
$18.38
MODV
-25.22%
$0.43
DFLI
-6.25%
$1.20
GSIT
+32.84%
$12.26
GOOGL
+2.94%
$267.57
AGNC
+0.53%
$10.25
AMC
+0.74%
$2.71
RGTZ
-12.30%
$13.47
CLF
+2.51%
$13.46
CODX
+264.98%
$1.28
ASST
+40.90%
$1.54
VHAI
-50.00%
$0.00
BYND
-7.77%
$2.01
BKYI
+54.18%
$1.18
CENN
-0.74%
$0.21
YDKG
+7.04%
$0.06
BURU
-4.59%
$0.38
NVDA
+2.25%
$186.26
INTC
+2.74%
$39.32
F
-4.44%
$13.22
DNN
+2.93%
$2.81
DVLT
+3.94%
$3.55
KITT
+23.04%
$2.16
HBAN
-3.42%
$15.52
T
+2.11%
$25.14
BITF
-1.97%
$4.51
JZXN
-5.44%
$0.34
TGL
+38.67%
$1.00
QCOM
+12.27%
$189.68
TSLA
+5.78%
$458.81
AXDX
-61.36%
$0.03
PLUG
-0.52%
$2.93
GPUS
+4.19%
$0.40
ABEV
+1.14%
$2.21
RGTI
+5.76%
$41.08
TLRY
-1.34%
$1.47
NUAI
+48.35%
$5.86
NEHC
+48.35%
$5.86
QBTS
+8.97%
$35.58
NAKA
+17.88%
$0.99
AMD
+1.19%
$255.93
SOFI
+3.33%
$29.97
CAN
-7.67%
$1.74
WTO
-14.44%
$0.05
RIG
-2.05%
$3.82
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BTG
-4.22%
$4.99
AAL
-3.15%
$13.34
ONDS
+6.50%
$7.94
PLTR
+3.34%
$190.80
IONZ
-10.49%
$3.41
SRM
+53.27%
$10.30
KDP
+7.16%
$29.10
NOK
+1.26%
$6.38
ADAP
-9.89%
$0.05
NIO
+2.82%
$7.09
LAES
-1.94%
$6.87
UUUU
-10.93%
$19.03
GRAB
+4.34%
$6.10
RF
-1.79%
$24.12
KDLY
+5.66%
$0.84
RIVN
+4.81%
$13.60
ACHR
+1.90%
$11.50
CIFR
-0.98%
$20.45
NVTS
-2.67%
$13.69
RR
+0.90%
$6.13
BBD
+1.34%
$3.39
WLGS
-5.57%
$0.04
JOBY
+1.16%
$16.31
RXRX
+2.77%
$6.20
IREN
+1.98%
$64.15
ETHD
-14.74%
$3.26
OGN
-22.05%
$7.14
QUBT
+3.83%
$16.12
ETWO
0.00%
$3.30
AIRE
+3.43%
$0.79
VIVK
-0.72%
$0.28
BTBT
+2.42%
$4.00
CJET
-7.05%
$0.10
MARA
+2.30%
$19.98
QS
+1.03%
$16.99
WGRX
-25.56%
$0.85
AFMD
-34.94%
$0.18
BMNR
+6.72%
$53.80
JBLU
+2.18%
$4.67
LUMN
+12.68%
$9.11
SNAP
-0.31%
$7.92
EOSE
+11.83%
$16.05
CRWV
+7.46%
$132.55
AAPL
+1.18%
$265.94
OPI
-16.97%
$0.20
AMZN
+1.55%
$227.69
MP
-6.88%
$65.93
KLG
-9.05%
$13.35
IONQ
+5.90%
$63.86
PFE
-0.14%
$24.72
GRYP
-10.38%
$1.38
VALE
+0.41%
$11.45
RECT
-7.18%
$3.23
SOUN
+2.25%
$18.38
MODV
-25.22%
$0.43
DFLI
-6.25%
$1.20
GSIT
+32.84%
$12.26
GOOGL
+2.94%
$267.57
AGNC
+0.53%
$10.25
AMC
+0.74%
$2.71
RGTZ
-12.30%
$13.47
CLF
+2.51%
$13.46
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.